P-113d, an Antimicrobial Peptide Active against Pseudomonas aeruginosa, Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients

Antimicrobial peptides are a source of novel agents that could be useful for treatment of the chronic lung infections that afflict cystic fibrosis (CF) patients. Efficacy depends on antimicrobial activity against the major pathogens of CF patients, Pseudomonas aeruginosa, Staphylococcus aureus, and...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Sajjan, Umadevi S., Tran, Linh T., Sole, Nuria, Rovaldi, Christopher, Akiyama, Alan, Friden, Phillip M., Forstner, Janet F., Rothstein, David M.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2001
Schlagworte:	Susceptibility
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90850/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709321/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3437-3444.2001
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!